Stocks:
5,167
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.23T
24h Vol:
$10.06B
Dominance:
MSFT:4.87%
Stocklytics Platform
Instrument logo  CELZ
Creative Medical Technology Holdings
CELZ
49 / 100
Penny Stock
$4.83arrow_drop_up0.28%$0.01

Performance History

Stocklytics logo
Key Stats
Open$4.81
Prev. Close$4.81
EPS-3.76
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap6525390.00
PE Ratio-
LOWHIGH
Day Range4.81
4.87
52 Week Range3.93
10.28
Ratios
P/B Ratio0.68
Revenue-
Operating M. %-59,061.30%
Earnings$0.00
Earnings Growth %47.88%
EBITDA Margin %-
ROE %-40.34%
EPS-3.76

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

49vs 56. Market Avg.

All Score 49 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

CELZMARKET
Value5239
Quality3940
Ownership117
Growth4446
Dividends-38
check_circle

Creative Medical Technology Holdings's Price discount from all time high of 100% is great compared to market average of 43.16%. This indicates CELZ could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$726.31
24H (%)arrow_drop_down2.63%
24H ($)-$19.64
MARKET CAP$690.55B
PRICE$501.13
24H (%)arrow_drop_up1.61%
24H ($)$7.95
MARKET CAP$462.00B
PRICE$147.91
24H (%)arrow_drop_up1.48%
24H ($)$2.17
MARKET CAP$356.43B
PRICE$125.78
24H (%)arrow_drop_up0.43%
24H ($)$0.55
MARKET CAP$318.60B

About Creative Medical Technology Holdings (CELZ)

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Timothy Warbington
Headquarters
Phoenix
Employees
4
Exchange
NASDAQ
add Creative Medical Technology Holdings to watchlist

Keep an eye on Creative Medical Technology Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Creative Medical Technology Holdings's (CELZ) price per share?

The current price per share for Creative Medical Technology Holdings (CELZ) is $4.81. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Creative Medical Technology Holdings (CELZ)?

For Creative Medical Technology Holdings (CELZ), the 52-week high is $10.28, which is 113.75% from the current price. The 52-week low is $3.93, the current price is 22.39% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Creative Medical Technology Holdings (CELZ) a growth stock?

Creative Medical Technology Holdings (CELZ) has shown an average price growth of -61.55% over the past three years. It has received a score of 1 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Creative Medical Technology Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Creative Medical Technology Holdings (CELZ) stock price performance year to date (YTD)?

As of the latest data, Creative Medical Technology Holdings (CELZ) has a year-to-date price change of 4.57%. Over the past month, the stock has experienced a price change of -8.21%. Over the last three months, the change has been 13.18%. Over the past six months, the figure is 5.95%.

help
Is Creative Medical Technology Holdings (CELZ) a profitable company?

Creative Medical Technology Holdings (CELZ) has a net income of -$5.29M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -59.06K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$5.62M. Furthermore, the EBITDA is -$5.53M.

help
What is the market capitalization of Creative Medical Technology Holdings (CELZ)?

Creative Medical Technology Holdings (CELZ) has a market capitalization of $6.53M. The average daily trading volume is 10.13K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.